Liver Transplantation After Transarterial Chemoembolization and Radiotherapy for Hepatocellular Carcinoma with Vascular Invasion
暂无分享,去创建一个
Jong Hoon Kim | S. Yoon | G. Song | Sung‐Gyu Lee | M. Shin | Shin Hwang | C. Ahn | Ki‐Hun Kim | D. Moon | Y. Jeong | Jin-hong Park
[1] Y. Choi,et al. Macrovascular invasion is not an absolute contraindication for living donor liver transplantation , 2017, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[2] S. Lee. A Complete Treatment of Adult Living Donor Liver Transplantation: A Review of Surgical Technique and Current Challenges to Expand Indication of Patients , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[3] B. Choi,et al. 2014 KLCSG-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma: HCC Diagnostic Algorithm , 2014, Digestive Diseases.
[4] Lunan Yan,et al. Downstaging Advanced Hepatocellular Carcinoma to the Milan Criteria May Provide a Comparable Outcome to Conventional Milan Criteria , 2013, Journal of Gastrointestinal Surgery.
[5] W. Lau,et al. Surgical Resection Versus Conformal Radiotherapy Combined With TACE for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Comparative Study , 2013, World Journal of Surgery.
[6] H. Won,et al. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes. , 2012, International journal of radiation oncology, biology, physics.
[7] H. Shirato,et al. Efficacy of therapy for advanced hepatocellular carcinoma: Intra‐arterial 5‐fluorouracil and subcutaneous interferon with image‐guided radiation , 2011, Journal of gastroenterology and hepatology.
[8] W. Lau,et al. Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Prospective Comparative Study , 2011, Annals of Surgical Oncology.
[9] D. Sze,et al. Transarterial Chemoinfusion for Hepatocellular Carcinoma as Downstaging Therapy and a Bridge toward Liver Transplantation , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[10] K. Sugimachi,et al. Impact of Des-Gamma-Carboxy Prothrombin and Tumor Size on the Recurrence of Hepatocellular Carcinoma After Living Donor Liver Transplantation , 2009, Transplantation.
[11] L. Bolondi,et al. Liver Transplantation for Hepatocellular Carcinoma: Results of Down‐Staging in Patients Initially Outside the Milan Selection Criteria , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[12] W. Chapman,et al. Outcomes of Neoadjuvant Transarterial Chemoembolization to Downstage Hepatocellular Carcinoma Before Liver Transplantation , 2008, Annals of surgery.
[13] K. Sung,et al. Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large‐volume center , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[14] S. Uemoto,et al. Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[15] M. Makuuchi,et al. Living Donor Liver Transplantation for Hepatocellular Carcinoma: Tokyo University Series , 2007, Digestive Diseases.
[16] J. Joh,et al. HCC in Living Donor Liver Transplantation: Can We Expand the Milan Criteria? , 2007, Digestive Diseases.
[17] K. Lee,et al. Liver Transplantation for Hepatocellular Carcinoma in Patients Who Do Not Meet the Milan Criteria , 2007, Digestive Diseases.
[18] Y. Maehara,et al. Extended Indication for Living Donor Liver Transplantation in Patients With Hepatocellular Carcinoma , 2007, Transplantation.
[19] Y. Cho,et al. The role of 18F‐FDG‐PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients , 2006 .
[20] G. Otto,et al. Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[21] K. Sung,et al. Lessons learned from 1,000 living donor liver transplantations in a single center: How to make living donations safe , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[22] J. Lee,et al. Three‐dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma , 2005, Cancer.
[23] L. Qin,et al. A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus. , 2005, International journal of radiation oncology, biology, physics.
[24] K. Sugimura,et al. Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma. , 2003, International journal of radiation oncology, biology, physics.
[25] L. Ferrell,et al. Liver transplantation for hepatocellular carcinoma: Comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[26] J. Furuse,et al. Radiotherapy After Transcatheter Arterial Chemoembolization for Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus , 2002, American journal of clinical oncology.
[27] A. Venook,et al. Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival , 2001, Hepatology.
[28] V. Mazzaferro,et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.
[29] A. Benson,et al. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. , 2010, Gastroenterology.
[30] T. Sauerbruch,et al. [Sorafenib in advanced hepatocellular carcinoma]. , 2009, Der Internist.
[31] J. Barkun,et al. Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantation. , 2007, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[32] Y. Cho,et al. The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients. , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[33] J. Bruix,et al. Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification , 1999, Seminars in liver disease.